Risk Disclosure: This website's content is not investment advice and offers no trading guidance or related services. Per regulations from the PBOC and other authorities, users must be aware of virtual currency risks. Contact us / [email protected] ICP License: 琼ICP备2022009338号
TechFlow news, on July 18, NASDAQ-listed MEI Pharma (NASDAQ: MEIP) established a dedicated LTC treasury, to which it has already committed over $100 million.
Charlie Lee, founder of LTC, will join the board of directors of MEI Pharma. The LTC Foundation has also invested in MEI Pharma, believing that this treasury strategy aligns with the foundation's core mission of promoting global Litecoin adoption.
MEI Pharma (NASDAQ: MEIP), a publicly traded company on the U.S. stock market, has established a dedicated LTC treasury, to which it has committed over $100 million. Charlie Lee, founder of LTC, will join the board of directors of MEI Pharma. The LTC Foundation has also invested in MEI Pharma, stating that this treasury strategy aligns with the foundation's core mission of promoting global adoption of Litecoin.
Navigating Web3 tides with focused insights
